First Manhattan Co. LLC. / ABBV
First Manhattan Co. LLC.’s Abbvie Inc Position
Does First Manhattan Co. LLC. own Abbvie Inc (ABBV)? Yes — 604.8K shares worth $132M (+0.36% of its 13F portfolio) as of Q1 2026, down from 606.5K shares the prior filed quarter.
Position Value
$132M
Q1 2026
Shares
604.8K
% of Portfolio
+0.36%
Quarters Held
29
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 604.8K | $132M | +0.36% |
| Q4 2025 | 606.5K | $139M | +0.36% |
| Q3 2025 | 606.9K | $141M | +0.37% |
| Q2 2025 | 609.7K | $113M | +0.32% |
| Q1 2025 | 618.3K | $130M | +0.38% |
| Q4 2024 | 606.9K | $108M | +0.32% |
| Q3 2024 | 617.2K | $122M | +0.36% |
| Q2 2024 | 611.6K | $105M | +0.34% |
| Q1 2024 | 641.5K | $117M | +0.38% |
| Q4 2023 | 650.1K | $101M | +0.35% |
| Q3 2023 | 668.6K | $100M | +0.37% |
| Q2 2023 | 885.5K | $119M | +0.44% |
| Q1 2023 | 1.25M | $200M | +0.77% |
| Q4 2022 | 1.29M | $209M | +0.77% |
| Q3 2022 | 1.34M | $180M | +0.76% |
| Q2 2022 | 1.40M | $215M | +0.87% |
| Q1 2022 | 1.47M | $238M | +0.78% |
| Q4 2021 | 1.66M | $225M | +0.74% |
| Q3 2021 | 1.38M | $149M | +0.55% |
| Q2 2021 | 1.33M | $150M | +0.55% |
| Q1 2021 | 1.16M | $125M | +0.54% |
| Q4 2020 | 1.12M | $120M | +0.57% |
| Q3 2020 | 218.1K | $19M | +0.10% |
| Q2 2020 | 214.3K | $21M | +0.12% |
| Q1 2020 | 215.0K | $16M | +0.11% |
| Q4 2019 | 214.7K | $19M | +0.10% |
| Q3 2019 | 214.3K | $16M | +0.09% |
| Q2 2019 | 168.3K | $12M | +0.07% |
| Q4 2018 | 165.0K | $15M | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First Manhattan Co. LLC.’s full portfolio or all institutional holders of ABBV.